c-erbB-2/neu protein expression, DNA ploidy and S phase in breast cancer. 1996

R Dittadi, and F Calderazzo, and A Cabrelle, and S Di Fresco, and M Gion, and L Chieco-Bianchi
Center for the Study of Biological Markers of Malignancy, General Hospital, Venice, Italy.

DNA content and c-erbB2/neu protein (p185) expression were evaluated by flow-cytometry and ELISA, respectively, in 166 specimens of primary breast cancer. A non-diploid DNA content was found in 88 tumours (53%), with the DNA index ranging from 0.7-2.7. S phase fraction (SPF) evaluation, performed in 130 cases, showed significantly higher values in aneuploid than in diploid tumours (median values, 17.3% and 5.8%, respectively). Thirty-six tumours (21.6%) showed p185 overexpression, while 45 (27.1%) and 85 (51.3%) showed intermediate and low expression, respectively. A good correlation (P = 0.0023) was found between DNA content and p185 positivity. Tumours with high p185 values were mainly aneuploid, while tumours with intermediate or low expression had variable degrees of DNA content. Furthermore, p185 concentration was significantly higher in aneuploid than in diploid tumours (P = 0.009). The highest rate of p185 (+) cases and the highest p185 concentrations occurred in triploid (1.3 < D.I. < or = 1.7), compared to the other tumours. SPF values and p185 positivity rates were not significantly correlated in diploid and in aneuploid tumours.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011003 Ploidies The degree of replication of the chromosome set in the karyotype. Ploidy
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

R Dittadi, and F Calderazzo, and A Cabrelle, and S Di Fresco, and M Gion, and L Chieco-Bianchi
September 1993, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society,
R Dittadi, and F Calderazzo, and A Cabrelle, and S Di Fresco, and M Gion, and L Chieco-Bianchi
February 1990, Archives of pathology & laboratory medicine,
R Dittadi, and F Calderazzo, and A Cabrelle, and S Di Fresco, and M Gion, and L Chieco-Bianchi
April 2000, Diagnostic cytopathology,
R Dittadi, and F Calderazzo, and A Cabrelle, and S Di Fresco, and M Gion, and L Chieco-Bianchi
December 1992, Analytical and quantitative cytology and histology,
R Dittadi, and F Calderazzo, and A Cabrelle, and S Di Fresco, and M Gion, and L Chieco-Bianchi
March 1991, British journal of cancer,
R Dittadi, and F Calderazzo, and A Cabrelle, and S Di Fresco, and M Gion, and L Chieco-Bianchi
December 1991, Analytical and quantitative cytology and histology,
R Dittadi, and F Calderazzo, and A Cabrelle, and S Di Fresco, and M Gion, and L Chieco-Bianchi
January 1993, Cytopathology : official journal of the British Society for Clinical Cytology,
R Dittadi, and F Calderazzo, and A Cabrelle, and S Di Fresco, and M Gion, and L Chieco-Bianchi
September 1995, Cancer immunology, immunotherapy : CII,
R Dittadi, and F Calderazzo, and A Cabrelle, and S Di Fresco, and M Gion, and L Chieco-Bianchi
July 1990, Annals of oncology : official journal of the European Society for Medical Oncology,
R Dittadi, and F Calderazzo, and A Cabrelle, and S Di Fresco, and M Gion, and L Chieco-Bianchi
August 1992, Cancer letters,
Copied contents to your clipboard!